IA
JUNO

IFG Advisory’s Juno Therapeutics, Inc. JUNO Stock Holding History

IFG Advisory’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,082
Closed -$323K – 354
2017
Q4 		$323K Buy
+7,082
New +$353K 0.07% 251

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFG Advisory's JUNO Position: Q1 2018 in Review

IFG Advisory sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,082 shares — an estimated $323K sold.

IFG Advisory first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $323K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • IFG Advisory reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • IFG Advisory sold 7,082 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $323K.
  • IFG Advisory first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • IFG Advisory's Juno Therapeutics, Inc. position peaked at $323K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on IFG Advisory's 13F filing for Q1 2018, filed 26 Apr 2018.